ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
974Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 252 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 0.89% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 12,312 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 4.4% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 657 shares, the number of shares held decreased 1.02% compared to the previous period and now represents 1.18% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 21,690 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 9.37% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 27,207 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 3.29% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 21,897 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 4.33% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 13,599 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 6.04% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 116,046 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 7.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 126 shares, the number of shares held decreased 0.97% compared to the previous period and now represents 0.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 10,161 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 2.84% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 123,849 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 1.66% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 3,303 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 4.6% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 657 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 1.48% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 17,568 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 3.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Exact Sciences by 783 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 0.35% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 1,602 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 0.94% of the total position.
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 18,432 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 6.61% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 14,274 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 5.62% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 1,566 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 1.71% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 29,682 shares, the number of shares held decreased 1.01% compared to the previous period and now represents 2.72% of the total position.
Go to Tiger App to see more news